Reach Us +441474556909
Role Of The Bethesda System In Cervical Cancer Screening: A 5 Year Study | 36687
ISSN: 2375-4273

Health Care : Current Reviews
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

3rd Indo-Global Summit & Expo on Healthcare

Sadaf Haiyat, Kafil Akhtar, Rana K Sherwani, Shamshad Ahmad and Noora Sayeed
Jawaharlal Nehru Medical College- Aligarh, India
ScientificTracks Abstracts: Health Care: Current Reviews
DOI: 10.4172/2375-4273.C1.011
Cervical cancer is the second most common type of cancer among women worldwide. Exfoliative cytology remains the mainstay for screening of pre-cancerous lesions. A comparative study of conventional Pap smear with revised Bethesda system in the detection of cervical intra-epithelial neoplasia was done over a period of 5 years study in the Jawaharlal Nehru Medical College, Aligarh. Total of 318 premalignant lesions were noted, most commonly were in the fourth decade. Conventional system reported around 18.3% of premalignant lesions while it was 31.8% when reviewed by Bethesda system. The incidence of various pre-malignant lesions diagnosed were atypical squamous cells of undetermined significance (ASC-US) in 2.3% of cases, atypical squamous cells, cannot exclude HSIL (ASC-H) in 0.4%, low grade squamous intraepithelial lesions (LSIL) in 18.7%, high grade squamous intraepithelial lesions (HSIL) in 6%, atypical glandular cells of undetermined significance (AGUS) in 3.5% and atypical glandular cells favoring neoplasia in 0.9% cases. However, no premalignant glandular lesions were reported in conventional reporting of cervical cancer. The revised Bethesda system for cervical cancer has proven to be more valuable in detecting pre-malignant lesions especially glandular lesions which are usually missed on conventional reporting.

Sadaf Haiyat is currently pursuing MD Pathology from Jawaharlal Nehru Medical College, Aligarh Muslim University, India. She has published 5 papers in reputed national and international journals.

Email: [email protected]

image PDF   |   image HTML

Relevant Topics

Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2018-19
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Business & Management Journals


[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

nutritionjo[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001Extn: 9042

© 2008- 2018 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version